Postmarketing Surveillance Study for Use of Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (Menactra) in the Republic of Korea
Latest Information Update: 14 Apr 2020
At a glance
- Drugs Meningococcal vaccine groups A C Y W-135 conjugate (Primary)
- Indications Meningococcal infections
- Focus Adverse reactions
- Sponsors Sanofi Pasteur
- 10 Apr 2020 Status changed from active, no longer recruiting to completed.
- 14 Feb 2019 Planned number of patients changed from 1264 to 600.
- 11 Dec 2018 Planned End Date changed from 1 Feb 2019 to 1 Jun 2019.